In a surprising move, the HHS has terminated a $590 million contract with Moderna for H5 avian influenza vaccine development, raising alarms among health experts amidst rising H5N1 threats.
The announcement of a $500 million NIH project to develop a vaccine platform using outdated technology has divided experts, sparking concerns about the future of pandemic preparedness and funding priorities.
In a controversial move, NIH officials may be pushing to eliminate mRNA vaccine technology from grant applications, signaling a potential halt in vital medical research. Scientists express fears over job security and funding.
Discover the shocking findings of a Yale University study linking a debilitating syndrome to Covid vaccines. Learn about the experiences of individuals who have suffered vaccine injuries and the challenges they faced in getting their conditions recognized.
Groundbreaking personalized mRNA vaccine demonstrates potential in reducing the recurrence of pancreatic cancer post-surgery by training immune cells to fight the disease. Learn how this innovative approach may revolutionize cancer treatment.
